![Ronald E. Cape](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ronald E. Cape
No open positions remaining
Profile
Ronald E.
Cape served as Chairman at Caprion Pharmaceuticals, Cetus Corp., and BYTC Corp.
He also served as Director at CASI Pharmaceuticals, Inc. and Neurobiological Technologies, Inc. Additionally, he was a Director at Gelesis, Inc., San Francisco Opera Association, and Follica, Inc. He also served as an Advisor at EARLYBIRD LLC.
Dr. Cape earned an MBA from Harvard University in 1955, a doctorate from McGill University in 1967, and an undergraduate degree from Princeton University in 1953.
Former positions of Ronald E. Cape
| Companies | Position | End |
|---|---|---|
BYTC Corp.
 BYTC Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chairman | 2009-01-29 |
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Director/Board Member | 2008-06-04 |
| NEUROBIOLOGICAL TECHNOLOGIES, INC. | Director/Board Member | 2007-12-30 |
Caprion Pharmaceuticals, Inc.
 Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Chairman | 2007-03-15 |
San Francisco Opera Association
 San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Director/Board Member | - |
Training of Ronald E. Cape
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs for treating cancer and inflammatory diseases | Health Technology |
Neurobiological Technologies, Inc.
 Neurobiological Technologies, Inc. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
Caprion Pharmaceuticals, Inc.
Caprion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovered and developed pharmaceutical products | Health Technology |
Gelesis, Inc.
 Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Francisco Opera Association
San Francisco Opera Association Movies/EntertainmentConsumer Services Owns and operates an opera theater | Consumer Services |
EARLYBIRD LLC
 EARLYBIRD LLC Investment ManagersFinance Earlybird seeks to invest in companies led by outstanding people who are creating major new markets. Most investments are made in the early-stages or during a phase of expansion while the company is privately held. The firm seeks a team with an entrepreneurial vision and skill-set with highly personal commitments to the success of the venture. They invest in companies that demonstrate vision and creativity with large, untapped market opportunities, and seek entrepreneurs with a passion for their ideas and the determination, commitment and skills needed to transform their vision into a successful business. The target investment’s market must be sufficiently expansive, with growth to enable significant annual sales in a few years. After a sufficient developmental period, they expect the company’s products and services to maintain growth potential and also generate a high level of profitability. Products or services should have a clear and sustainable competitive advantage based on product features protected by strong intellectual property and other barriers to entry while posting a moderate technology risk. Earlybird’s investment focus is software/information technology, communications, healthcare and convergent technologies. | Finance |
BYTC Corp.
BYTC Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Follica, Inc.
 Follica, Inc. Other Consumer ServicesConsumer Services Develops therapies for hair follicle disorders | Consumer Services |
- Stock Market
- Insiders
- Ronald E. Cape
